International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

Dan H. Barouch(Beth Israel Deaconess Medical Center), Jaap Goudsmit, Glenda Gray(South African Medical Research Council), Keith G. Mansfield(Primate Conservation), Lori F. Maxfield(Beth Israel Deaconess Medical Center), Susan Buchbinder(San Francisco Department of Public Health), David Ng’ang’a(Beth Israel Deaconess Medical Center), Nelson L. Michael(Walter Reed Army Institute of Research), Guy de Bruyn(University of Namur), Peter Abbink(Beth Israel Deaconess Medical Center), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Pauli N. Amornkul(International AIDS Vaccine Initiative), Angela Carville(Primate Conservation), Kara Brandariz(Beth Israel Deaconess Medical Center), Sandra V. Kik, Hannah Kibuuka(Makerere University Walter Reed Project), Maria Grazia Pau, Merlin L. Robb(University of Maryland, Baltimore), Omu Anzala(University of Nairobi), Michael S. Seaman(Beth Israel Deaconess Medical Center), Jill Gilmour(International AIDS Vaccine Initiative), Surita Roux(Desmond Tutu HIV Foundation), Sharon L King(Beth Israel Deaconess Medical Center), Rebecca Dilan(Beth Israel Deaconess Medical Center), Lindsey R. Baden(Brigham and Women's Hospital), Sarah Clark(Beth Israel Deaconess Medical Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Raphael Dolin(Beth Israel Deaconess Medical Center), Faruk Sinangil(Global Solutions for Infectious Diseases), Gerrit Jan Weverling, Athmanundh Dilraj(South African Medical Research Council)
Cited by 307


Related Papers